Literature DB >> 20573580

Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis.

Nicolas Van de Velde1, Marc Brisson, Marie-Claude Boily.   

Abstract

Mathematical models of HPV vaccine effectiveness and cost-effectiveness have produced conflicting results. The aim of this study was to use mathematical models to compare and isolate the impact of the assumptions most commonly made when modeling the effectiveness of HPV vaccines. Our results clearly show that differences in how we model natural immunity, herd immunity, partnership duration, HPV types, and waning of vaccine protection lead to important differences in the predicted effectiveness of HPV vaccines. These results are important and useful to assist modelers/health economists in choosing the appropriate level of complexity to include in their models, provide epidemiologists with insight on key data necessary to increase the robustness of model predictions, and help decision makers better understand the reasons underlying conflicting results from HPV models. Copyright 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20573580     DOI: 10.1016/j.vaccine.2010.05.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women.

Authors:  Xiaomeng Ma; Katherine Harripersaud; Kumi Smith; Christopher K Fairley; Huachun Zou; Zhuoru Zou; Yueyun Wang; Guihua Zhuang; Lei Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

Review 2.  A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus.

Authors:  Yiling Jiang; Aline Gauthier; Maarten J Postma; Laureen Ribassin-Majed; Nathalie Largeron; Xavier Bresse
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

3.  A Novel Representation of Vaccine Efficacy Trial Datasets for Use in Computer Simulation of Vaccination Policy.

Authors:  Mohammadamin Tajgardoon; Michael M Wagner; Shyam Visweswara; Richard K Zimmerman
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2018-05-18

Review 4.  Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies.

Authors:  Mohamed-Béchir Ben Hadj Yahia; Anaïs Jouin-Bortolotti; Benoît Dervaux
Journal:  Clin Drug Investig       Date:  2015-08       Impact factor: 2.859

5.  Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies.

Authors:  Marc D Ryser; Kevin McGoff; David P Herzog; David J Sivakoff; Evan R Myers
Journal:  Epidemics       Date:  2015-02-07       Impact factor: 4.396

6.  Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine.

Authors:  Harrell W Chesson; Jean-François Laprise; Marc Brisson; Lauri E Markowitz
Journal:  J Infect Dis       Date:  2016-02-09       Impact factor: 5.226

7.  Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.

Authors:  Sylvia L Ranjeva; Edward B Baskerville; Vanja Dukic; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano; Greg Dwyer; Sarah Cobey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

8.  Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.

Authors:  C Popadiuk; C L Gauvreau; M Bhavsar; C Nadeau; K Asakawa; W M Flanagan; M C Wolfson; A J Coldman; S Memon; N Fitzgerald; J Lacombe; A B Miller
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

Review 9.  The known unknowns of HPV natural history.

Authors:  Patti E Gravitt
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

10.  Sex in a lifetime: Sexual behaviors in the United States by lifetime number of sex partners, 2006-2010.

Authors:  Laura T Haderxhanaj; Jami S Leichliter; Sevgi O Aral; Harrell W Chesson
Journal:  Sex Transm Dis       Date:  2014-06       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.